BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ER, estrogen receptor AND Prognosis
78 results:

  • 1. Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.
    Verma A; Tomar R; Chaturvedi A; Dhankar N; Mallya V; Khurana N
    J Cancer Res Ther; 2024 Jan; 20(1):150-155. PubMed ID: 38554313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Effects of Fucoidan Derived from
    Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
    Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
    J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
    Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
    Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
    Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
    Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L; Cheng YW; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Application of 18 F-FES PET in Clinical Cancer Care : A Systematic Review.
    Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
    Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group].
    Karabajakian A; Genestie C; Meeus P; Guyon F; Llacer Moscardo C; Croce S; Taieb S; Duffaud F; Pautier P; Ray-Coquard I; Blay JY
    Bull Cancer; 2023; 110(7-8):836-843. PubMed ID: 37202293
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
    Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
    Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation.
    Oda H; Hedayati E; Lindström A; Shabo I
    PLoS One; 2023; 18(3):e0283003. PubMed ID: 36996051
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy.
    Yagishita S; Nishikawa T; Yoshida H; Shintani D; Sato S; Miwa M; Suzuki M; Yasuda M; Ogitani Y; Jikoh T; Yonemori K; Hasegawa K; Hamada A
    Clin Cancer Res; 2023 Jun; 29(12):2239-2249. PubMed ID: 36976261
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition.
    Li X; Wang F; Zhang X; Sun Q; Kuang E
    PLoS Pathog; 2023 Jan; 19(1):e1011103. PubMed ID: 36656913
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma.
    Zhu P; Li T; Li Q; Gu Y; Shu Y; Hu K; Chen L; Peng X; Peng J; Hao L
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551309
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.
    Samsuzzaman M; Jang BC
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740967
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary low-grade extrauterine endometrial stromal sarcoma: analysis of 10 cases with a review of the literature.
    Wu Y; Li N; Zhang R; Bai P
    World J Surg Oncol; 2022 Jan; 20(1):17. PubMed ID: 35027071
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Surfactin induces ER stress-mediated apoptosis via IRE1-ASK1-JNK signaling in human osteosarcoma.
    Wang GS; Chen JY; Chen WC; Wei IC; Lin SW; Liao KW; Yang TS; Liu JF
    Environ Toxicol; 2022 Mar; 37(3):574-584. PubMed ID: 34850538
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Suppression of estrogen receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
    Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
    Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.